MIG
TMO icon

McGuire Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

McGuire Investment Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9M Sell
27,805
-335
-1% -$161K 1.22% 24
2026
Q1 		$13.8M Sell
28,140
-5,199
-16% -$2.82M 1.56% 20
2025
Q4 		$19.3M Buy
33,339
+38
+0.1% +$21.5K 2.06% 16
2025
Q3 		$16.2M Sell
33,301
-378
-1% -$176K 1.83% 17
2025
Q2 		$13.7M Buy
33,679
+502
+2% +$210K 1.75% 16
2025
Q1 		$16.5M Buy
33,177
+745
+2% +$403K 2.45% 15
2024
Q4 		$16.9M Buy
32,432
+79
+0.2% +$43.4K 2.44% 14
2024
Q3 		$20M Buy
32,353
+556
+2% +$329K 2.82% 11
2024
Q2 		$17.6M Buy
31,797
+73
+0.2% +$41.8K 2.52% 14
2024
Q1 		$18.4M Sell
31,724
-30
-0.1% -$16.8K 2.69% 10
2023
Q4 		$16.9M Buy
31,754
+674
+2% +$326K 2.81% 12
2023
Q3 		$15.7M Buy
31,080
+725
+2% +$386K 3.03% 9
2023
Q2 		$15.8M Sell
30,355
-610
-2% -$329K 2.95% 12
2023
Q1 		$17.8M Sell
30,965
-1,541
-5% -$869K 3.55% 6
2022
Q4 		$17.9M Buy
32,506
+6
+0% +$3.18K 3.87% 2
2022
Q3 		$16.5M Buy
32,500
+190
+0.6% +$106K 3.76% 3
2022
Q2 		$17.6M Sell
32,310
-214
-0.7% -$118K 3.78% 4
2022
Q1 		$19.2M Buy
32,524
+128
+0.4% +$73.5K 3.52% 7
2021
Q4 		$21.6M Sell
32,396
-65
-0.2% -$40.6K 3.56% 7
2021
Q3 		$18.5M Buy
32,461
+310
+1% +$170K 3.49% 8
2021
Q2 		$16.2M Sell
32,151
-333
-1% -$157K 3.08% 8
2021
Q1 		$14.8M Buy
32,484
+2,401
+8% +$1.15M 3.13% 8
2020
Q4 		$14M Buy
30,083
+29
+0.1% +$13.6K 3.47% 7
2020
Q3 		$13.3M Buy
30,054
+77
+0.3% +$31.8K 3.95% 4
2020
Q2 		$10.9M Sell
29,977
-2,529
-8% -$848K 3.77% 7
2020
Q1 		$9.22M Buy
32,506
+5
+0% +$1.58K 3.84% 7
2019
Q4 		$10.6M Buy
32,501
+436
+1% +$132K 3.14% 11
2019
Q3 		$9.34M Buy
32,065
+197
+0.6% +$56.4K 3.06% 9
2019
Q2 		$9.36M Buy
31,868
+277
+0.9% +$76.3K 2.97% 10
2019
Q1 		$8.65M Buy
31,591
+13
+0% +$3.23K 2.83% 10
2018
Q4 		$7.07M Buy
31,578
+269
+0.9% +$63.1K 2.67% 12
2018
Q3 		$7.64M Buy
+31,309
New +$7.2M 2.53% 13

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

McGuire Investment Group's TMO Position: Q2 2026 in Review

McGuire Investment Group reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q2 2026, selling an estimated $161K and leaving 27,805 shares worth $13.9M. The position accounts for 1.22% of the portfolio, ranked #24.

McGuire Investment Group first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. The position peaked at $21.6M in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • McGuire Investment Group held 27,805 shares of Thermo Fisher Scientific worth $13.9M as of Q2 2026.
  • McGuire Investment Group sold 335 Thermo Fisher Scientific shares in Q2 2026, an estimated $161K.
  • Thermo Fisher Scientific made up 1.22% of McGuire Investment Group's portfolio in Q2 2026, its #24 holding.
  • McGuire Investment Group first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
  • McGuire Investment Group's Thermo Fisher Scientific position peaked at $21.6M in Q4 2021.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on McGuire Investment Group's 13F filing for Q2 2026, filed 27 Jul 2026.